Literature DB >> 26705150

Formulation design and evaluation of amorphous ABT-102 nanoparticles.

Rajan Jog1, Sumit Kumar1, Jie Shen1, Nital Jugade2, David Cheng Thiam Tan2, Rajeev Gokhale2, Diane J Burgess3.   

Abstract

Amorphous nanoparticles are able to enhance the kinetic solubility and concomitant dissolution rates of BCS class II and BCS class II/IV molecules due to their characteristic increased supersaturation levels, smaller particle size and greater surface area. A DoE approach was applied to investigate formulation and spray drying process parameters for the preparation of spray dried amorphous ABT-102 nanoparticles. Stability studies were performed on the optimized formulations to monitor physical and chemical changes under different temperature and humidity conditions. SLS/soluplus and SLS/PVP K25 were the best stabilizer combinations. Trehalose was used to prevent nanoparticle aggregation during spray drying. Particle size distribution, moisture content, PXRD, PLM, FTIR and in vitro dissolution were utilized to characterize the spray dried nanoparticle formulations. The formulations prepared using soluplus showed enhanced dissolution rate compared to those prepared using PVP K25. Following three months storage, it was observed that the formulations stored at 4°C were stable in terms of particle size distribution, moisture content, and crystallinity, whereas those stored at 25°C/60%RH and 40°C/75%RH were unstable. A predictive model to prepare stable solid spray dried amorphous ABT-102 nanoparticles, incorporating both formulation and process parameters, was successfully developed using multiple linear regression analysis. Published by Elsevier B.V.

Entities:  

Keywords:  Amorphous nanoparticles; DoE; In vitro dissolution testing; Spray drying

Mesh:

Substances:

Year:  2015        PMID: 26705150     DOI: 10.1016/j.ijpharm.2015.12.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo.

Authors:  Ying-Chun Zeng; Sha Li; Chang Liu; Tao Gong; Xun Sun; Yao Fu; Zhi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-01-23       Impact factor: 6.150

Review 2.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.